Viewing Study NCT00259103


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2025-12-25 @ 4:48 PM
Study NCT ID: NCT00259103
Status: COMPLETED
Last Update Posted: 2014-05-07
First Post: 2005-11-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor
Sponsor: Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module